You're starting to sound like JB's sidekick .... lol
Well the FDA will let us know soon enough what they think - my bet is it will be a 2 month PDUFA date and that MSB will have a stem cell treatment approved well before CYP ever gets to the BLA submission stage ... whether it is Remestemcel-L for sr-GVHD or Rexlemestrocel-L for CHF via the Accelerated Approval route - at least we have two shots at FDA approval in the next 12 months. CYP on the other hand has dosed one patient in their first ever FDA / USA trial so literally years to go before they even look at an FDA BLA submission .... as you were
banter and General Discussion, page-10314
-
- There are more pages in this discussion • 1,836 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |